Company Filing History:
1 out of 19 
1 out of 132 
1 out of 5,094 
Years Active: 2016
Title: Celia Dechavanne: Innovator in Neonatal Serological Diagnosis
Introduction
Celia Dechavanne is a prominent inventor based in Paris, France. She has made significant contributions to the field of neonatal serological diagnosis. Her innovative work focuses on improving the early detection of diseases transmitted from mother to child.
Latest Patents
Celia holds a patent for a method of neonatal serological diagnosis. This invention provides a method for determining the amino acid polymorphisms of the heavy gamma chain of immunoglobulins G through a proteomic approach. The method effectively distinguishes between the immunoglobulins of the mother and those of the newborn in a blood sample obtained during the first months of the child's life. Additionally, the invention relates to the early diagnosis of vertically transmitted diseases in neonates. It also includes peptides distinctive of G3m and IGHG3 alleles, along with a kit comprising these peptides.
Career Highlights
Throughout her career, Celia has worked with esteemed organizations such as the Institut de Recherche pour le Développement (IRD) and Université Paris Descartes. Her work in these institutions has furthered research in immunology and neonatal health.
Collaborations
Celia has collaborated with notable colleagues, including Florence Migot-Nabias and François Guillonneau. These partnerships have enhanced her research and contributed to advancements in her field.
Conclusion
Celia Dechavanne's innovative contributions to neonatal serological diagnosis highlight her dedication to improving healthcare for newborns. Her work continues to impact the field positively, paving the way for future advancements.